Screening helps detect prostate cancer early for treatment

Prostate cancer, the most common cancer in men, often presents no symptoms in its early stages, necessitating regular screenings. Diagnosis typically involves a PSA test, digital rectal exam, and potentially a prostate biopsy. The disease primarily affects men over 50, arising from uncontrolled growth of prostate gland cells. Treatment options, tailored to the individual, depend on the cancer's stage and overall health, potentially involving surgery, radiation, or hormone therapy. Distinguishing prostate cancer from benign prostatic hyperplasia (BPH) is crucial, as BPH causes urinary issues but doesn't increase cancer risk. Early detection through screening is vital for effective treatment.